Common side effects include nausea, vomiting, diarrhea, constipation, stomach discomfort, and decreased appetite
Due to rising reports of fraudulent, tainted, or unsafe shipments of semaglutide and tirzepatide entering the U.S., the FDA has created a green list of API manufacturers whose facilities meet its safety standards
Anna Garrett is a menopause expert and Doctor of Pharmacy
Its not always easy to distinguish between the two based on symptoms alone, especially in someone with active disease, she says
Route of Administration: Oral (Capsules, Tablets, or Liquid)
Thornton K, and Gorenstein DG